Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
Status:
Completed
Trial end date:
2009-03-24
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well giving celecoxib with or without eflornithine
works in preventing colorectal cancer in patients with familial adenomatous polyposis.
Chemoprevention is the use of certain drugs to keep cancer from forming. The use of celecoxib
and eflornithine may keep cancer from forming in patients with familial adenomatous
polyposis.